Newtyn Management, LLC - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 26 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Newtyn Management, LLC ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2024$976,741
-10.2%
930,230
-40.8%
0.20%
-8.9%
Q4 2023$1,087,840
-19.4%
1,572,023
-12.7%
0.21%
-35.7%
Q3 2023$1,350,180
-35.2%
1,800,000
-1.5%
0.33%
-32.3%
Q2 2023$2,083,054
-9.9%
1,827,240
+18.6%
0.49%
+8.4%
Q1 2023$2,311,380
+34.2%
1,540,920
+33.3%
0.45%
+27.9%
Q4 2022$1,721,786
+167.8%
1,155,561
+178.4%
0.36%
+151.8%
Q3 2022$643,000
-31.7%
415,0000.0%0.14%
-20.8%
Q2 2022$942,000415,0000.18%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
Ikarian Capital, LLC 650,000$403,0650.07%
Deuterium Capital Management, LLC 11,000$6,8210.01%
BOOTHBAY FUND MANAGEMENT, LLC 172,835$107,1750.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 77,900$48,3060.00%
XTX Topco Ltd 14,047$8,7110.00%
Leo Wealth, LLC 14,845$9,2050.00%
NORTHERN TRUST CORP 25,983$16,1120.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Cresset Asset Management, LLC 19,671$12,1980.00%
Banque Cantonale Vaudoise 3,900$20.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders